Novartis Message Board - Msg: 1145681

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Novartis

NVS 126.31

-0.2%

12:16 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: AMF who wrote (8)	4/8/1997 7:16:00 AM
From: Jim Garrison	of 296

To all: Article on Novartis, Glaxo, and Merck 1,2,3 in market share. biz.yahoo.com Also, I had a friend of mine get Merrill Lynch report on Novartis - they like it and they rate it Interim Term 1,Buy; Long term 1,Buy; Income 7 Same/Higher and Invest Risk A low. Shame they have the ADR on the OTC Bulletin Board and it's so hard to get info, quotes or research. Dow Jones quotes doesn't want to hear it. The gal at Schwab Research indicated that they have been getting lotsa requests on Novartis, but S&P doesn't do reports on Bulletin Board stocks. Wierd they are spending all that money on advertising (full page ads in Invest Biz Daily and others and tv) and you really cant get any info on the stock. Like it's in the Pink Sheets for one of the largest companies in the world! Does anyone know if they are considering moving to a real exchange? My opinion only. Good trading. jim garrison

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next